Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -42.06% is 23% below its 5-year average of -34.07%, around the middle of its 5-year range (-84.57%–16.67%).
112.07% below its 12-month average of -19.83%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 12.94%.
OPERATING MARGIN
-42.06%
OPERATING MARGIN AVG TTM
-19.83%
OPERATING MARGIN AVG 3Y
-20.28%
OPERATING MARGIN AVG 5Y
-34.07%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-112.07%
CURRENT VS 3Y AVG
-107.43%
CURRENT VS 5Y AVG
-23.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 645 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
LENSAR Inc
Market Cap
$82.16M
Operating Margin
-42.06%
TTM Avg
-19.83%
3Y Avg
-20.28%
5Y Avg
-34.07%
Market Cap
$82.17M
Operating Margin
-408.41%
TTM Avg
-360.51%
3Y Avg
-288.53%
5Y Avg
-284.25%
Market Cap
$82.69M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$83.18M
Operating Margin
-3242.47%
TTM Avg
-1621.23%
3Y Avg
-1058.13%
5Y Avg
-747.59%
Market Cap
$83.43M
Operating Margin
29.69%
TTM Avg
-17.51%
3Y Avg
-923.94%
5Y Avg
-894.93%
Market Cap
$80.89M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$84.58M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$85.04M
Operating Margin
-5271.69%
TTM Avg
-2635.84%
3Y Avg
-2669.01%
5Y Avg
-3573.08%
Market Cap
$80.04M
Operating Margin
-52.96%
TTM Avg
-64.09%
3Y Avg
-81.91%
5Y Avg
-87.35%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LENSAR Inc (LNSR) | $82.16M | -42.06% | -19.83% | -20.28% | -34.07% |
| Nutriband Inc. (NTRB)vs › | $82.17M | -408.41% | -360.51% | -288.53% | -284.25% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| MediciNova, Inc. (MNOV)vs › | $83.18M | -3242.47% | -1621.23% | -1058.13% | -747.59% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.43M | 29.69% | -17.51% | -923.94% | -894.93% |
| Citius Oncology, Inc. (CTOR)vs › | $80.89M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Humacyte, Inc. (HUMA)vs › | $85.04M | -5271.69% | -2635.84% | -2669.01% | -3573.08% |
| Pulmonx Corporation (LUNG)vs › | $80.04M | -52.96% | -64.09% | -81.91% | -87.35% |
| Cardiff Oncology, Inc. (CRDF)vs › | $85.53M | -8256.32% | -7689.73% | -8755.63% | -8045.81% |
Gross Margin
48.0%
Operating Margin
-42.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 12.94% |
| 2026-03-31 | 16.67% |
| 2025-12-31 | -30.70% |
| 2025-09-30 | -52.95% |
| 2025-06-30 | -45.13% |
| 2025-03-31 | -40.89% |
| 2024-12-31 | -7.71% |
| 2024-09-30 | -7.48% |
| 2024-06-30 | -12.27% |
| 2024-03-31 | -26.92% |
| 2023-12-31 | -24.46% |
| 2023-09-30 | -20.83% |
| 2023-06-30 | -23.87% |
| 2023-03-31 | -52.85% |
| 2022-12-31 | -25.54% |
| 2022-09-30 | -52.70% |
| 2022-06-30 | -84.57% |
| 2022-03-31 | -71.55% |
| 2021-12-31 | -34.86% |
| 2021-09-30 | -74.53% |
| 2021-06-30 | -55.23% |
| 2021-03-31 | -73.83% |
| 2020-12-31 | -82.67% |
| 2020-09-30 | -65.95% |
| 2020-06-30 | -76.14% |
| 2020-03-31 | -52.47% |
| 2019-12-31 | -22.83% |
| 2019-09-30 | -66.15% |
| 2019-06-30 | -38.90% |
| 2019-03-31 | -38.90% |
